Clinical Trials
341 trialsPhase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
University of Ulm
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
PedAL BCU, LLC
LBL 2018
University Hospital Muenster
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Karolinska University Hospital
Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
Fred Hutchinson Cancer Center
CLL17
German CLL Study Group
Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System
Poitiers University Hospital
BBT-II
University of Rochester
PD1-VEN-CAG
Fujian Medical University Union Hospital
Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients
Alliance for Clinical Trials in Oncology
Interfant-21
Princess Maxima Center for Pediatric Oncology
VAH vs VA in Newly Diagnosed Elderly AML
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
First Affiliated Hospital of Zhejiang University
IMPACT-AML
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
Stichting Hemato-Oncologie voor Volwassenen Nederland
Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT
Ruijin Hospital
FLUBUTBI
Hackensack Meridian Health
Auto-LLC 2001
University Hospital, Caen
VAG-3+7-G
Institute of Hematology & Blood Diseases Hospital, China
(HEM-FLU)
Asan Medical Center
TROPHY-15
The First Affiliated Hospital of Soochow University
Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML
The First Affiliated Hospital of Soochow University
VENP-A-QUI
PETHEMA Foundation
Comparison of VA and D/IA Induction Regimens in Elderly Fit Acute Myeloid Leukemia Patients
Institute of Hematology & Blood Diseases Hospital, China
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
Dartmouth-Hitchcock Medical Center
Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients
M.D. Anderson Cancer Center
05-001: Treatment of Acute Lymphoblastic Leukemia in Children
Dana-Farber Cancer Institute
Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax
Peking University People's Hospital
Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
City of Hope Medical Center
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Dana-Farber Cancer Institute
PATH
Ottawa Hospital Research Institute
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
Alliance for Clinical Trials in Oncology
AZABAC
Centre Henri Becquerel
Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment
Goethe University
CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT
Ruijin Hospital
Rose Geranium in Sesame Oil Nasal Spray for the Improvement of Nasal Vestibulitis Symptoms in Cancer Patients Receiving Chemotherapy
Mayo Clinic
IMM01+Azacitidine VS Placebo +Azacitidine in Patients With Newly Diagnosed Chronic Myelomonocytic Leukemia (CMML1-2)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
AML-DS-2025
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
MATCH
University of Texas Southwestern Medical Center
BOOST-IC
Monash University
PETALs
Hospices Civils de Lyon
Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL
Nanfang Hospital, Southern Medical University
CAALL-F01
Assistance Publique - Hôpitaux de Paris
CAMS-Ph+ B-ALL
Institute of Hematology & Blood Diseases Hospital, China
EVOLVE 1
Stichting Hemato-Oncologie voor Volwassenen Nederland
A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL
German CLL Study Group
Effectiveness of Medium-Dose Cytarabine Combined With Venetoclax for Consolidation Therapy in Elderly Patients With Intermediate to High-Risk Acute Myeloid Leukemia
The First Hospital of Jilin University
SEVENAZA
Gustave Roussy, Cancer Campus, Grand Paris
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
University of Ulm
ATG Plus Low-dose PT-Cy for GVHD Prevention
Peking University People's Hospital